News | January 23, 2013

Ablation Devices to Be the Fastest Growing Segment in the U.S. Nonvascular Interventional Radiology Device Market

Overall market to grow moderately to $295 million by 2017, according to Millennium Research Group

January 23, 2013 — According to Millennium Research Group (MRG), the segment of the U.S. nonvascular interventional radiology device market with the fastest growth and greatest potential is ablation devices, comprising radiofrequency (RF) ablation, cryoablation and microwave ablation devices. The overall market will grow moderately to $295 million by 2017.

Ablation devices offer a minimally invasive alternative to traditional surgical treatment of liver, prostate, kidney and lung cancers, and this segment is growing quickly because of the increasing popularity of minimally invasive treatments and the rising incidence of these soft tissue cancers.

RF ablation is the most established device type, but microwave ablation and cryoablation are growing rapidly, due to some advantages these types of ablation offer. Microwave ablation devices can produce larger ablation zones and don’t suffer as much from the heat sink effect that can handicap RF ablation. Growth in microwave ablation devices has stalled growth in RF ablation, and this segment of the market will slightly decline through 2017.

Microwave ablation devices are currently sold mainly by smaller companies with limited distribution networks. This has made them attractive acquisition targets by more established companies. For example, AngioDynamics, a leader in RF ablation, recently made a large investment in Microsulis, a microwave ablation company.

Cryoablation devices are the only kind of ablation device that can be used to treat prostate cancer. Urologists and interventional radiologists both use cryoablation to treat kidney cancer, using differing techniques.

“Cryoablation is more versatile than other ablation devices because its effects do not need to be permanent,” said MRG Analyst Sean Messenger. “As a result, it can be useful in indications outside of cancer, most prominently in pain palliation, another growing market. Competitors see the opportunity for significant growth, leading Endo Health Solutions, a company with a large pain franchise and a focus on pain palliation, to acquire the top cryoablation manufacturer, HealthTronics, in 2010.”

Millennium Research Group’s U.S. Markets for Nonvascular Interventional Radiology Devices 2013 report includes unit, installed base, average selling price and revenue information, along with market drivers and limiters and competitive landscape for ablation devices, percutaneous drainage catheters and soft tissue biopsy needles in the United States.

For more information: www.MRG.net, www.DecisionResourcesGroup.com

Related Content

GE's OEC Elite CFD

GE's OEC Elite CFD

Feature | Mobile C-Arms | April 18, 2018 | Jeff Zagoudis
The market for mobile C-arm technology has been steady for the last several years, according to Jamie Dildy, BS, R.T.
Medical Societies Issue Revised, Patient-Centered Measures for Stroke Interventions
News | Stroke | April 02, 2018
Revised guidelines for the nonsurgical, image-guided interventional treatment of acute ischemic stroke will ensure...
Radiologist Uses Virtual Reality as Interventional Radiology Teaching Tool

Ziv Haskal, M.D., of the University of Virginia Health System, steps into virtual reality. Image courtesy of Josh Barney, UVA Health System

News | Interventional Radiology | March 27, 2018
Physicians, trainees and even laypeople can now stand right beside an expert radiologist as he performs one of the most...
3-D Printed Models Improve Medical Student Training
News | Medical 3-D Printing | March 23, 2018
March 23, 2018 — A relatively inexpensive...
ECR 2018 Spotlights Artificial Intelligence and Current Radiology Trends
News | Interventional Radiology | February 21, 2018
The European Congress of Radiology (ECR) announced the theme of its 2018 annual meeting, Feb. 28-March 4 in Vienna...
Varian Signs Agreement to Acquire Sirtex
News | Radiation Therapy | January 31, 2018
January 31, 2018 — Varian Medical Systems announced it has signed an agreement to acquire all the outstanding shares
Imricor Announces Enrollment Completion for Clinical Study on Vision-MR Ablation Catheter
News | Interventional Radiology | January 23, 2018
January 23, 2018 – Imricor Medical Systems announced completion of enrollment for the...
Minimally Invasive Treatment Provides Relief from Back Pain

Lumbar spine MRI showing disc herniation and nerve root at baseline and one month after treatment

News | Interventional Radiology | January 11, 2018
The majority of patients were pain free after receiving a new image-guided pulsed radiofrequency treatment for low back...
Guerbet Announces Acquisition of Accurate Medical Therapeutics
News | Interventional Radiology | January 08, 2018
Guerbet announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init